Symptoms include sudden severe upper abdominal pain, pain radiating to your back, nausea accompanied by vomiting, elevated heart rate, and fever
This becomes more important once you stop, when the medication is no longer reducing your hunger
In the matched nave cohorts, 20% of tirzepatide ( N = 2125) and 18% of semaglutide ( N = 1909) patients had follow-up HbA1c data
Overall, these findings indicate that targeting both GIPR and GLP-1R in the CNS with peptideantibody conjugates, enabling GIPR blockade together with GLP-1R agonism, enhances weight loss
Most are mild and self-limiting
This is one of the most frequently asked questions in the aesthetics and weight loss industry